From The Medical Letter on Drugs and Therapeutics | December 17, 2014
A Stool DNA Test (Cologuard) for Colorectal Cancer Screening
The FDA has approved a stool DNA test to screen average-risk adults ≥50 years old for colorectal cancer.
The FDA has approved Cologuard (Exact Sciences), a stool DNA test, to screen average-risk adults ≥50 years old for colorectal cancer.
Once a month, JAMA selects for publication one article previously published in The Medical Letter.
Previous Publication: This article was previously published: The Medical Letter on Drugs and Therapeutics. October 13, 2014;56(1453):100-101.
©The Medical Letter Inc.
About The Medical Letter: The Medical Letter is a nonprofit organization that publishes biweekly new drug evaluations and treatment recommendations. The Medical Letter does not accept advertisements, gifts, grants, or donations. Financial support comes solely from sales of subscriptions, books, software, continuing education materials, and licenses.
Editors: Mark Abramowicz, MD, Editor in Chief; Gianna Zuccotti, MD, MPH, Executive Editor; Jean-Marie Pflomm, PharmD, Editor
No hay comentarios:
Publicar un comentario